Dr. Frederick Gibson, MD

Claim this profile

Boston Medical Center Dermatology Clinic

Studies Squamous Cell Carcinoma

Studies Breast Cancer

1 reported clinical trial

2 drugs studied

Area of expertise

1Squamous Cell Carcinoma

Frederick Gibson, MD has run 1 trial for Squamous Cell Carcinoma. Some of their research focus areas include:

Stage I

Stage II

2Breast Cancer

Frederick Gibson, MD has run 1 trial for Breast Cancer. Some of their research focus areas include:

Stage I

Stage II

Affiliated Hospitals

Boston Medical Center Dermatology Clinic

Clinical Trials Frederick Gibson, MD is currently running

More about Frederick Gibson, MD

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial

Treatments Frederick Gibson, MD has experience with

5-Fluorouracil
Calcipotriene

Breakdown of trials Frederick Gibson, MD has run

Squamous Cell Carcinoma

5-Fluorouracil + Calcipotriene Cream for Skin Cancer

Breast Cancer

5-Fluorouracil + Calcipotriene Cream for Skin Cancer

Basal Cell Carcinoma

5-Fluorouracil + Calcipotriene Cream for Skin Cancer

Vulval Intraepithelial Neoplasia

5-Fluorouracil + Calcipotriene Cream for Skin Cancer

Skin Cancer

5-Fluorouracil + Calcipotriene Cream for Skin Cancer

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

What does Frederick Gibson, MD specialize in?

Frederick Gibson, MD focuses on Squamous Cell Carcinoma and Breast Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage I patients, or patients who are Stage II.

Is Frederick Gibson, MD currently recruiting for clinical trials?

Yes, Frederick Gibson, MD is currently recruiting for 1 clinical trial in Boston Massachusetts. If you're interested in participating, you should apply.

Are there any treatments that Frederick Gibson, MD has studied deeply?

Yes, Frederick Gibson, MD has studied treatments such as 5-Fluorouracil, Calcipotriene.

What is the best way to schedule an appointment with Frederick Gibson, MD?

Apply for one of the trials that Frederick Gibson, MD is conducting.

What is the office address of Frederick Gibson, MD?

The office of Frederick Gibson, MD is located at: Boston Medical Center Dermatology Clinic, Boston, Massachusetts 02118 United States. This is the address for their practice at the Boston Medical Center Dermatology Clinic.

Is there any support for travel costs?

The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.

Top trials Frederick Gibson, MD is currently running

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Directories

Locations

Psychology Related

Treatments

Cities

···

Dr. Frederick Gibson, MD

Boston Medical Center Dermatology Clinic

Area of expertise

Affiliated Hospitals

Clinical Trials Frederick Gibson, MD is currently running

More about Frederick Gibson, MD

Other Doctors you might be interested in

Frequently asked questions

Personalize Your Experience

Save Your Preferences

Understand How the Site Is Used

Dr. Frederick Gibson, MD

Boston Medical Center Dermatology Clinic

Area of expertise

Affiliated Hospitals

Clinical Trials Frederick Gibson, MD is currently running

5-Fluorouracil + Calcipotriene Cream

for Skin Cancer

This trial compares a standard cancer-killing cream with a new, potentially more effective cream. It targets patients with less aggressive skin cancers. The new cream might work better by combining two ingredients to kill cancer cells and prevent new ones from forming.

More about Frederick Gibson, MD

Other Doctors you might be interested in

Frequently asked questions